School of Psychology and Public Health, La Trobe University, VIC, 3086, Australia.
Menzies Centre for Health Governance, School of Regulation and Global Governance, Australian National University, 8 Fellows Road Acton, Canberra, ACT, 2000, Australia.
Health Place. 2023 Sep;83:103051. doi: 10.1016/j.healthplace.2023.103051. Epub 2023 Jun 8.
This paper presents a political economy analysis of global inequities in access to COVID-19 vaccines, treatments, and diagnostic tests. We adapt a conceptual model used for analysing the political economy of global extraction and health to examine the politico-economic factors affecting access to COVID-19 health products and technologies in four interconnected layers: the social, political, and historical context; politics, institutions, and policies; pathways to ill-health; and health consequences. Our analysis finds that battles over access to COVID-19 products occur in a profoundly unequal playing field, and that efforts to improve access that do not shift the fundamental power imbalances are bound to fail. Inequitable access has both direct effects on health (preventable illness and death) and indirect effects through exacerbation of poverty and inequality. We highlight how the case of COVID-19 products reflects broader patterns of structural violence, in which the political economy is structured to improve and lengthen the lives of those in the Global North while neglecting and shortening the lives of those in the Global South. We conclude that achieving equitable access to pandemic response products requires shifting longstanding power imbalances and the institutions and processes that entrench and enable them.
本文对全球在获取 COVID-19 疫苗、治疗方法和诊断检测方面的不平等现象进行了政治经济学分析。我们借鉴了用于分析全球开采与健康的政治经济学的概念模型,从四个相互关联的层面考察了影响获取 COVID-19 卫生产品和技术的政治经济因素:社会、政治和历史背景;政治、制度和政策;导致健康不良的途径;以及健康后果。我们的分析发现,在获取 COVID-19 产品的竞争中,各方所处的条件极不平等,而如果不改变根本的权力失衡,旨在改善获取途径的努力注定会失败。获取途径不平等既对健康产生直接影响(可预防的疾病和死亡),也通过加剧贫困和不平等产生间接影响。我们强调了 COVID-19 产品案例如何反映了更广泛的结构性暴力模式,在这种模式下,政治经济结构旨在改善和延长北方国家人民的寿命,而忽视和缩短南方国家人民的寿命。我们的结论是,要实现公平获取大流行病应对产品,需要改变长期存在的权力失衡以及使这些失衡长期存在和成为可能的制度和进程。